Status
Conditions
Treatments
About
Colorectal cancer patients with metastases (mCRC) at response under first-line chemotherapy are candidates for an convenient maintenance treatment.
Full description
Colorectal cancer is one of the most common malignant tumors, with the morbidity of approximate 100 million cases per year. About 40% of patients present with metastatic (stage IV) colorectal cancer at the time of diagnosis, and about 25% of patients with local lesion will ultimately develop metastatic disease.Therefore, our study is designed to investigate that colorectal cancer patients with metastases (mCRC) at response under first-line chemotherapy are candidates for an convenient maintenance treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients who achieved objective response or stable disease after 16-24 weeks first line chemotherapy Signed informed consent
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
80 participants in 2 patient groups
Loading...
Central trial contact
Dong Yan, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal